Duke Cancer Center — Durham, North Carolina

Public research footprint of Duke Cancer Center, compiled from the ClinicalTrials.gov public registry.

233

Registered studies

128

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lung Non-Small Cell Carcinoma · Recurrent Ovarian Carcinoma · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Stage IIIB Lung Cancer AJCC v8

Recently updated registry entries

NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)
NCT06900595 — Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug… (Recruiting)
NCT06876714 — ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Duke Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.